Theriva Biologics (TOVX) Other Non-Current Liabilities (2014 - 2026)
Theriva Biologics' Other Non-Current Liabilities was $7.17 million in Q2 2026, down 29.4% from $10.16 million a year earlier and down 18.9% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Liabilities at Theriva Biologics came in at $10 million, up 43.5% from FY2024.
- Other Non-Current Liabilities shows a three-year compound annual growth rate of 11.5% (FY2022 to FY2025).
- In earlier years, Other Non-Current Liabilities was $6.97 million in FY2024 (+11.1%), $6.27 million in FY2023 (-13.0%) and $7.21 million in FY2022.
- The Q2 2026 figure marks the lowest quarterly Other Non-Current Liabilities since Q1 2025.
- Compared with a year earlier, Other Non-Current Liabilities was higher in six of the last eight quarters, with growth averaging 25.7%.
- The best year-over-year quarter for Other Non-Current Liabilities over five years was Q3 2023 (growth of 165.3%); the worst was Q1 2023 (a decline of 55.5%).
- Per Business Quant data, TOVX's Other Non-Current Liabilities in the three quarters before Q2 2026 was $8.84 million (Q1 2026), $10 million (Q4 2025) and $10.79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Theriva Biologics | 10.56 Mn | 10.56 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.17 Mn |
| Mar 31, 2026 | 8.84 Mn |
| Dec 31, 2025 | 10.00 Mn |
| Sep 30, 2025 | 10.79 Mn |
| Jun 30, 2025 | 10.16 Mn |
| Mar 31, 2025 | 5.69 Mn |
| Dec 31, 2024 | 6.97 Mn |
| Sep 30, 2024 | 6.79 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Mar 31, 2024 | 6.48 Mn |
| Dec 31, 2023 | 6.27 Mn |
| Sep 30, 2023 | 5.94 Mn |
| Jun 30, 2023 | 5.77 Mn |
| Mar 31, 2023 | 5.41 Mn |
| Dec 31, 2022 | 7.21 Mn |
| Sep 30, 2022 | 2.24 Mn |
| Jun 30, 2022 | 2.20 Mn |
| Mar 31, 2022 | 12.16 Mn |
| Dec 31, 2018 | 302,000.00 |
| Sep 30, 2018 | 329,000.00 |
API Access
Theriva Biologics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();